MicroRNAs (miRNAs) encapsulated by extracellular vesicles (EVs) are found in body fluids of patients with malignant diseases as well as with those having a better health. The difference in the EV-encapsulated miRNAs between these two groups of people could be used as a signature to identify various diseases. The miRNAs present in urine could serve as biomarkers for detecting cancer. Unfortunately, the concentration of EVs in urine is extremely low (<0.01 volume %) and hence the most commonly used method of extraction – ultracentrifugation is not capable of extracting nearly 90% of the miRNA species, due to their low abundance. Recently, a nanowire-based device anchored to a microfluidic substrate is fabricated for the efficient collection of EVs and in situ extraction of various miRNAs of different sequences, which is believed to open the gates for urine-based early diagnoses and medical checkups for cancer (Yasui et al., Sci. Adv. 2017;3: e1701133).
Si (100) served as the base substrate (Fig. 1(a)), which was coated with a positive photoresist followed by channel patterning using photo lithography (Fig. 1(b)). A 140 nm thick Cr layer was sputter deposited (Fig. 1(c)), followed by removal of the photoresist layer and thermal oxidation of the Cr layer at 400 °C for 2 h (Fig. 1(d)). The thermally oxidized Cr layer served as the seed layer for subsequent growth of ZnO nanowires using a solution mixture of 15 mM hexamethylenetetramine (HMTA) and 15 mM zinc nitrate hexahydrate at 95 °C for 3 h (Fig. 1(e)). PDMS was poured over the ZnO nanowire grown substrate and cured (Fig. 1(f)). Subsequently, the PDMS was removed from the Si substrate (Fig. 1(g)) and the ZnO nanowires in the PDMS were transferred to another PDMS substrate. The transferred nanowires were uniformly and deeply buried into PDMS while their slightly emerged heads served as growth points for the second nanowire growth (Fig. 1(h)), which was carried out by immersing the PDMS in a solution mixture of 15 mM HMTA and 15 mM zinc nitrate hexahydrate at 95 °C for 3 h (Fig. 1(i)). To enhance contact events between the ZnO nanowires and the EVs as well as to avoid any pressure drop, the ZnO nanowire embedded PDMS substrate was anchored to a herringbone-structured PDMS substrate (Fig. 1(j)).
Fig. 1 (a-j) Various stages involved in the fabrication of nanowire-based device; and (k) schematic of the collection and extraction of EV–encapsulated miRNAs.
The nanowire-based device is capable of detecting around 1000 types of species of miRNAs when compared to the conventional ultracentrifugation method. Using this device, it is possible to extract EV–encapsulated miRNAs within 40 min (collection, 20 min; extraction, 20 min) by introducing just 1 ml of urine sample followed by 1 ml of lysis buffer into the device (Fig. 1(k)). In contrast, the ultracentrifugation method requires 20 ml of urine sample and more than 5 h for collection and extraction. The device enables a four-fold increase in the miRNA expression level with a larger variety of extracted species of miRNAs. The ZnO nanowire-based device is found to be superior to the commonly used ultracentrifugation method in terms of treatment time and RNA extraction efficiency. This attribute is due to its large surface area of ZnO nanowires and their positively charged surface (isoelectric point of 9.50 at pH 6 to 8), which electrostatically attracts the negatively charged EVs in urine sample at pH 6-8. In addition, the mechanical stability of ZnO nanowires, which are firmly anchored to the PDMS substrate helps to retain their strength during buffer flow and enhances the extraction efficiency. The positively charged surface of ZnO nanowires offers benefit in collecting negatively charged objects in urine samples, including exosomes, microvesicles, and EV-free miRNAs.
The ZnO nanowire-based device is believed to help in the early diagnoses and timely medical checkups based on urine miRNA analysis. The method is capable of identifying urinary miRNAs that could potentially serve as biomarkers for detecting bladder, prostate lung, pancreas, and liver cancer.
T.S.N. Sankara Narayanan

Fig. 1 various stages involved in the fabrication of flexible sensor
Fig. 2 Morphological features of (a) SWCNTs coated cotton yarn; (b, c) cotton@SWCNTs/ZnO@PVDF; (c) magnified image of ZnO nanorods
Fig. 3 (a) Schematic representation of the sensor used for monitoring temperature, motions and liquid flow; (b) Linear I-V curves of the sensor measured under different fluid temperature.
Fig. 4 (a, b) Demonstration of the bending and pressing motion; (c) output voltage generated by the sensor under different bending angles; and (d) output voltage generated by the sensor under compression at different frequencies.
Fig. 5 (a) Experimental set-up used to monitor liquid flow using the sensor; (b) I-V curves of the sensor measured under a narrow fluid temperature range; (c) output voltage generated by the sensor under different fluid input pressure; and (d) output current generated by the sensor under different pulse frequencies.